Induction of sustained remission in early inflammatory arthritis with the combination of infliximab plus methotrexate: the DINORA trial

Tanja Stamm,Klaus Machold,Daniel Aletaha,F. Alasti,Peter E. Lipsky,David S. Pisetsky,Robert Landewé,Désirée van der Heijde,Alexandre Sepriano,Martin Aringer,Dimitri Boumpas,Gerd R. Burmester,Maurizio Cutolo,Wolfgang Ebner,Winfried Graninger,Tom Huizinga,Georg Schett,Hendrik Schulze-Koops,Paul-Peter Tak,Emilio Martín-Mola,Ferdinand C. Breedveld,Josef S. Smolen

Induction of sustained remission in early inflammatory arthritis with the combination of infliximab plus methotrexate: the DINORA trial

2018

Background In the present study, we explored the effects of immediate induction therapy with the anti-tumour necrosis factor (TNF)α antibody infliximab (IFX) plus methotrexate (MTX) compared with MTX alone and with placebo (PL) in patients with very early inflammatory arthritis.

Keywords:

Immunology
Placebo
Rheumatology
Tumor necrosis factor alpha
Rheumatoid arthritis
Gastroenterology
Infliximab
Necrosis
Methotrexate
Early Inflammatory Arthritis
Internal medicine
Medicine
Clinical endpoint
Synovitis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations